lubabegron trade name experior veterinary drug used reduce ammonia emissions animals ammonia emissions concern agricultural production detrimental effects environment human health animal lubabegron approved us food drug administration use feedlot first drug approved reducing ammonia also approved use lubabegron betaadrenergic receptor antagonist activity lubabegron receptors prevents stimulation Î²ar found heart tracheabronchi humans avoids potential negative side effects associated receptor activation antagonist behavior lubabegron could decrease lipolysis adipose tissue whereas agonist activity could increase skeletal muscle hypertrophy possibly due differences second messenger systems enzyme expression skeletal muscle compared adipose httpsenwikipediaorgwikilubabegron